Intracavitary doxorubicin in malignant effusions.

Subjects

Subjects :

Abdomen
Aged
Doxorubicin toxicity
Female
Humans
Injections
Middle Aged
Pleural Effusion
Adenocarcinoma drug therapy
Breast Neoplasms drug therapy
Doxorubicin administration & dosage
Exudates and Transudates
Lung Neoplasms drug therapy
Mesothelioma drug therapy
Ovarian Neoplasms drug therapy

Details

Language :

English

ISSN :

0140-6736

Volume :

1

Issue :

8112

Database :

MEDLINE

Journal :

Lancet (London, England)

Publication Type :

Editorial & Opinion

Accession number :

85046

Full Text :

https://doi.org/10.1016/s0140-6736(79)92937-4